Edgewise Therapeutics Announces Pricing of Initial Public Offering BOULDER, Colo.–(BUSINESS WIRE)– Edgewise Therapeutics, Inc. (NASDAQ: EWTX), a clinical-stage biopharmaceutical company focused on developing orally bioavailable, small molecule therapies...
BrightInsight and AstraZeneca Collaborate to Enhance Disease Management BrightInsight Accelerates Time to Market for the AstraZeneca AMAZE Disease Management Platform Within a Regulatory-Compliant Environment SAN JOSE, Calif., March 16, 2021 – BrightInsight, Inc.,...
ReViral and LianBio Announce Exclusive Collaboration and License Agreement to Develop and Commercialize Sisunatovir in China London and Research Triangle Park, N.C., and Shanghai and Princeton, N.J., March 2, 2021 – ReViral Ltd., a clinical-stage biopharmaceutical...
Kit Check®’s Bluesight® for Controlled Substances is Announced as Best in KLAS for Drug Diversion Monitoring in 2021 Best in KLAS Report For the second year running, Bluesight for Controlled Substances takes top marks in all product categories and receives a score of...
TRUVERIS EXPANDS LEADERSHIP TEAM WITH KEY APPOINTMENTS New CCO, CMO and Senior Industry Leaders to Further Accelerate Company Growth NEW YORK, January 20, 2021 – Truveris, a leading digital health company focused on reducing costs and improving access in pharmacy,...
Recent Comments